We investigated the relation between epithelial ovarian cancer and the use of oral contraceptives in a case-control study of 144 white women under the age of 60 who had ovarian cancer and 139 white women under 60 who were selected from the general population. We observed a decreased risk for ovarian cancer associated with the use of oral contraceptives in subjects 40 through 59 years of age at the time of the study. The relative risk, adjusted for parity, was 0.11, with 95 per cent confidence limits of 0.04 to 0.33. In contrast to the findings in older women, a decreased risk for ovarian cancer associated with oral-contraceptive use was not found in women under 40. In this group, the adjusted relative risk associated with any use of oral contraceptives was 1.98, with 95 per cent confidence limits of 0.74 to 5.27. The lowest risk for ovarian cancer associated with the use of oral contraceptives was observed in older parous subjects and in women who had discontinued use more than 10 years previously.
This article has been cited by other articles:
Tworoger, S. S., Fairfield, K. M., Colditz, G. A., Rosner, B. A., Hankinson, S. E.
(2007). Association of Oral Contraceptive Use, Other Contraceptive Methods, and Infertility with Ovarian Cancer Risk. Am J Epidemiol
166: 894-901
[Abstract][Full Text]
Marquez, R. T., Baggerly, K. A., Patterson, A. P., Liu, J., Broaddus, R., Frumovitz, M., Atkinson, E. N., Smith, D. I., Hartmann, L., Fishman, D., Berchuck, A., Whitaker, R., Gershenson, D. M., Mills, G. B., Bast, R. C. Jr., Lu, K. H.
(2005). Patterns of Gene Expression in Different Histotypes of Epithelial Ovarian Cancer Correlate with Those in Normal Fallopian Tube, Endometrium, and Colon. Clin. Cancer Res.
11: 6116-6126
[Abstract][Full Text]
Kjaer, S. K, Mellemkjaer, L., Brinton, L. A, Johansen, C., Gridley, G., Olsen, J. H
(2004). Tubal sterilization and risk of ovarian, endometrial and cervical cancer. A Danish population-based follow-up study of more than 65 000 sterilized women. Int J Epidemiol
33: 596-602
[Abstract][Full Text]
Modugno, F.
(2004). Ovarian Cancer and Polymorphisms in the Androgen and Progesterone Receptor Genes: A HuGE Review. Am J Epidemiol
159: 319-335
[Abstract][Full Text]
Riman, T., Dickman, P. W., Nilsson, S., Correia, N., Nordlinder, H., Magnusson, C. M., Persson, I. R.
(2002). Risk Factors for Invasive Epithelial Ovarian Cancer: Results from a Swedish Case-Control Study. Am J Epidemiol
156: 363-373
[Abstract][Full Text]
Barnes, M. N., Grizzle, W. E., Grubbs, C. J., Partridge, E. E.
(2002). Paradigms for Primary Prevention of Ovarian Carcinoma. CA Cancer J Clin
52: 216-225
[Abstract][Full Text]
Syed, V., Ulinski, G., Mok, S. C., Yiu, G. K., Ho, S.-M.
(2001). Expression of Gonadotropin Receptor and Growth Responses to Key Reproductive Hormones in Normal and Malignant Human Ovarian Surface Epithelial Cells. Cancer Res.
61: 6768-6776
[Abstract][Full Text]
Purdie, D. M., Siskind, V., Bain, C. J., Webb, P. M., Green, A. C.
(2001). Reproduction-related Risk Factors for Mucinous and Nonmucinous Epithelial Ovarian Cancer. Am J Epidemiol
153: 860-864
[Abstract][Full Text]
Ness, R. B., Cottreau, C.
(1999). Possible Role of Ovarian Epithelial Inflammation in Ovarian Cancer. JNCI J Natl Cancer Inst
91: 1459-1467
[Abstract][Full Text]
Previous
